• Explore /
  • Poster
  • / Outcomes of patients (pts) with metastatic renal cell carcinoma (mRCC) and sarcomatoid dedifferentiation (sRCC) after treatment with immune checkpoint inhibitors (ICI): A single-institution retrospective study.

Outcomes of patients (pts) with metastatic renal cell carcinoma (mRCC) and sarcomatoid dedifferentiation (sRCC) after treatment with immune checkpoint inhibitors (ICI): A single-institution retrospective study.

Abstract Poster

Authors

null

Jeremy Aaron Ross

University of Texas MD Anderson Cancer Center, Houston, TX

Jeremy Aaron Ross , Barrett Z. McCormick , Jianjun Gao , Pavlos Msaouel , Matthew T. Campbell , Amado J. Zurita , Amishi Yogesh Shah , Eric Jonasch , Surena F. Matin , Christopher G. Wood , Jose A. Karam , Padmanee Sharma , Nizar M. Tannir

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2018 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Genitourinary (Nonprostate) Cancer

Track

Genitourinary Cancer—Kidney and Bladder

Sub Track

Kidney Cancer

Citation

J Clin Oncol 36, 2018 (suppl; abstr 4583)

DOI

10.1200/JCO.2018.36.15_suppl.4583

Abstract #

4583

Poster Bd #

409

Abstract Disclosures

Similar Posters

First Author: Charlee Nardin

First Author: Thierry Landre

First Author: Lorenzo Pilla

Poster

2020 ASCO-SITC Clinical Immuno-Oncology Symposium

Efficacy and toxicities of immune checkpoint inhibitors (ICIs) in advanced melanoma: A single institution experience.

Efficacy and toxicities of immune checkpoint inhibitors (ICIs) in advanced melanoma: A single institution experience.

First Author: Karim Welaya